Mason Street Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Mason Street Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $3.37 Million - $4.96 Million	-54,879 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $5,740 - $11,183	131 Added 0.24%	54,879 $4.21 Million
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $33,973 - $52,449	-1,023 Reduced 1.83%	54,748 $2.36 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $65,979 - $109,300	2,526 Added 4.74%	55,771 $2.41 Million
Q4 2019 Feb 19, 2020	BUY	$28.14 - $73.01 $587,703 - $1.52 Million	20,885 Added 64.54%	53,245 $3.38 Million
Q3 2019 Nov 05, 2019	BUY	$26.26 - $34.86 $18,670 - $24,785	711 Added 2.25%	32,360 $912,000
Q2 2019 Aug 12, 2019	BUY	$17.43 - $28.82 $551,642 - $912,124	31,649 New	31,649 $839,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.